Cipher Pharmaceuticals (CPH) Competitors

Cronos Group (TSE:CRON) and Cipher Pharmaceuticals (TSE:CPH) are both small-cap medical companies, but which is the better investment? We will compare the two businesses based on the strength of their analyst recommendations, institutional ownership, profitability, risk, dividends, valuation, media sentiment, earnings and community ranking.

Does the MarketBeat Community believe in CRON or CPH?

Cipher Pharmaceuticals received 112 more outperform votes than Cronos Group when rated by MarketBeat users. Likewise, 61.99% of users gave Cipher Pharmaceuticals an outperform vote while only 50.74% of users gave Cronos Group an outperform vote.

Company	Underperform	Outperform
Cronos Group	Outperform Votes 69 50.74%	Underperform Votes 67 49.26%
Cipher Pharmaceuticals	Outperform Votes 181 61.99%	Underperform Votes 111 38.01%

Is CRON or CPH more profitable?

Cipher Pharmaceuticals has a net margin of 59.92% compared to Cronos Group's net margin of -42.65%. Cipher Pharmaceuticals' return on equity of 17.93% beat Cronos Group's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Cronos Group	-42.65%	-4.40%	-3.73%
Cipher Pharmaceuticals	59.92%	17.93%	7.90%

Do analysts rate CRON or CPH?

Cipher Pharmaceuticals has a consensus target price of C$14.75, suggesting a potential upside of 18.19%. Given Cipher Pharmaceuticals' stronger consensus rating and higher probable upside, analysts plainly believe Cipher Pharmaceuticals is more favorable than Cronos Group.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Cronos Group	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00
Cipher Pharmaceuticals	0 Sell rating(s)	2 Hold rating(s)	1 Buy rating(s)	1 Strong Buy rating(s)	2.75

Does the media favor CRON or CPH?

In the previous week, Cipher Pharmaceuticals had 1 more articles in the media than Cronos Group. MarketBeat recorded 1 mentions for Cipher Pharmaceuticals and 0 mentions for Cronos Group. Cipher Pharmaceuticals' average media sentiment score of 0.67 beat Cronos Group's score of 0.00 indicating that Cipher Pharmaceuticals is being referred to more favorably in the news media.

Company	Overall Sentiment
Cronos Group	Neutral
Cipher Pharmaceuticals	Positive

Do insiders & institutionals have more ownership in CRON or CPH?

16.0% of Cronos Group shares are owned by institutional investors. Comparatively, 1.4% of Cipher Pharmaceuticals shares are owned by institutional investors. 46.4% of Cronos Group shares are owned by company insiders. Comparatively, 42.0% of Cipher Pharmaceuticals shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.

Which has better valuation and earnings, CRON or CPH?

Cipher Pharmaceuticals has lower revenue, but higher earnings than Cronos Group. Cronos Group is trading at a lower price-to-earnings ratio than Cipher Pharmaceuticals, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Cronos Group	C$76.86M	9.52	-C$32.78M	-C$0.18	-15.41
Cipher Pharmaceuticals	C$19.03M	11.77	C$11.41M	C$0.91	13.78

Which has more volatility and risk, CRON or CPH?

Cronos Group has a beta of 1.02, suggesting that its share price is 2% more volatile than the S&P 500. Comparatively, Cipher Pharmaceuticals has a beta of 1.2, suggesting that its share price is 20% more volatile than the S&P 500.

Summary

Cipher Pharmaceuticals beats Cronos Group on 16 of the 19 factors compared between the two stocks.